Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients

Open access

Abstract

Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Two consecutively negative SARS-CoV-2 viral RNA test ( interval ≥ 24 hours), improved respiratory symptoms and obvious absorption of inflammation in pulmonary imaging are the discharge criteria for COVID-19 patients. The clearance profile of viral RNA in the upper respiratory tract specimens, including nasopharyngeal swab and/or oropharyngeal swabs, is related to innate immune cells such as Natural Killer cells. A total of 168 patients were included for the study. In this cohort, non-severe and severe groups showed significant differences in white blood cells, neutrophils, lymphocytes, basophils and platelets counts, as well as in infection related parameters such as CRP and serum cytokine IL-6. For lymphocyte subsets tests at admission, the severe group displayed significantly lower cell counts than the non-severe group. Higher counts of total T cells, CD4 + T cells, CD8 + T cells, and NK cells in peripheral blood showed a significant correlation with the shorter time taken to obtain the first negative viral RNA test and first positive IgM/ IgG antibody test. The number of B cells was only correlated with time to achieve the first positive IgM/IgG test. The count of NK cells was also correlated with a higher level of IgG antibody (p = 0.025). The lymphocytopenia group had a significantly worse survival rate (p = 0.022) and a longer duration (p = 0.023) of viral shedding than the normal lymphocyte count group. A lower NK cell count correlates the most with the worse survival rate (p<0.001) and a longer duration (p<0.001) of viral shedding. This study suggests the potential value of allo-Natural Killer cell therapy as an universal COVID-19 treatment strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40164-021-00199-1

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Survival and hazardous analysis. In lymphocytopenia subgroups analysis, p = 0.022 for survival and p = 0.023 for viral shedding duration. In NK cell lymphocytopenia p < 0.001 for survival and p < 0.001 for viral shedding duration
Fig. 1 Survival and hazardous analysis. In lymphocytopenia subgroups analysis, p = 0.022 for survival and p = 0.023 for viral shedding duration. In NK cell lymphocytopenia p < 0.001 for survival and p < 0.001 for viral shedding durationCC BY · PubMed Central
Fig. 2 The innate and adaptive immune response to SARS-CoV-2 infection. Hypothesis of the innate and adaptive immune response to SARS-CoV-2 infection. NK cells have direct killing effect on SARS-CoV-2 infected cells, as well as participate in antibody-dependent cellular cytotoxicity. Through inhibiting and activating receptors, NK cells recognize infected cells. Once activated, the degranulation of NK cells induces the releasing of perforin and granzyme which directly lyse infected cells. NK cells express CD16A, which participates in antibody-dependent cellular cytotoxicity. Meanwhile, NK cells also interact with dendritic cells in antigen presenting process and affect adaptive immune response. Monocytes can secret IL-6 that acts as inflammatory cytokine, resulting in the activation of other immune cells
Fig. 2 The innate and adaptive immune response to SARS-CoV-2 infection. Hypothesis of the innate and adaptive immune response to SARS-CoV-2 infection. NK cells have direct killing effect on SARS-CoV-2 infected cells, as well as participate in antibody-dependent cellular cytotoxicity. Through inhibiting and activating receptors, NK cells recognize infected cells. Once activated, the degranulation of NK cells induces the releasing of perforin and granzyme which directly lyse infected cells. NK cells express CD16A, which participates in antibody-dependent cellular cytotoxicity. Meanwhile, NK cells also interact with dendritic cells in antigen presenting process and affect adaptive immune response. Monocytes can secret IL-6 that acts as inflammatory cytokine, resulting in the activation of other immune cellsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 47

Metadata

Authors
Bao, C., Tao, X., Cui, W., Hao, Y., Zheng, S., Yi, B., Pan, T., Young, K. H., & Qian, W.
Affiliations
  • Second Affiliated Hospital of Zhejiang University (CN)
  • Second Military Medical University (CN)
  • Duke University (US)
  • First Affiliated Hospital of Soochow University (CN)
Corresponding author
  • Young, Ken H.
  • Qian, Wenbin
Venue
Experimental Hematology & Oncology
Published
2021-01-27
Volume
10
Issue
1
Pages
5-5
ISSN
2162-3619 (ISSN-L)
OpenAlex
W3124932440
Cited by
47
References
12
Citations by year
2025: 5 · 2024: 2 · 2023: 7 · 2022: 28 · 2021: 5
FWCI
3.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Experimental Hematology and Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
The Translation Research Grant of NCRCH (2020ZKZC01)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Keywords
COVID-19 pandemic, SARS-CoV-2, natural killer cells, viral RNA shedding, viral clearance, antibody response, IgM and IgG antibodies, lymphopenia, mortality, CD4+ T cells, CD8+ T cells, B cells, interleukin-6, C-reactive protein, innate immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients. https://app.cochat.ai/papers/10.1186/s40164-021-00199-1
The paper
Bao, C., Tao, X., Cui, W., Hao, Y., Zheng, S., Yi, B., Pan, T., Young, K. H., & Qian, W. (2021). Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-021-00199-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.